Novel evidence associates higher plasma α-synuclein levels and cognitive impairment in Parkinson's disease

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):808. doi: 10.1136/jnnp-2017-315821. Epub 2017 Jun 12.

Authors

Dag Aarsland^{1

2}, Anto P Rajkumar^{1

2}, Abdul Hye^{1

3}

Affiliations

¹ Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
² Mental Health of Older Adults and Dementia Clinical Academic Group, South London and Maudsley NHS Foundation Trust, London, UK.
³ NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation trust, London, UK.

PMID: 28607120
DOI: 10.1136/jnnp-2017-315821

No abstract available

Keywords: Dementia; cognition; parkinson's disease.

Publication types

Editorial
Comment

MeSH terms

Amyloid beta-Peptides
Cognitive Dysfunction
Dementia
Humans
Parkinson Disease*
alpha-Synuclein*

Substances

Amyloid beta-Peptides
alpha-Synuclein